Body

MUNICH – Data from a Phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy, according to researchers at the Duke Clinical Research Institute.

While the results of the study did not show a statistically significant difference in ischemic events among any of the four doses of apixaban evaluated, trends emerged that support further study, the scientists said.

Reston, Va.—In the largest multi-institutional study to date examining the impact of positron emission tomography (PET) in changing disease management of individuals with suspected recurrent colorectal cancer, researchers found that treatment plans were changed for more than half of patients, according to an article in the September issue of The Journal of Nuclear Medicine.

SAN FRANCISCO, CA--- Doctors and medical centers across the United States are debating the use of electronic health records (EHR). This month’s Ophthalmology, the journal of the American Academy of Ophthalmology, provides a look at Eye M.D.s’ actions and opinions on the issue. Also highlighted this month are two research studies that will help doctors identify patients who are most vulnerable to advanced age-related macular degeneration (AMD), the leading cause of severe vision loss in the United States and most Western countries.

With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center. Writing in the September issue of Pediatrics, the multicenter research team offers pediatricians a step-by-step tool for quickly identifying children with allergic reactions to vaccines, and a much-needed guide, they say, to safely immunize those who are allergic.

Academic health centers (AHCs) have a critical role in enabling, encouraging, and rewarding the sharing of biomedical research data, say a team of academics in this week's PLoS Medicine. "The leaders of medical schools and academic-affiliated hospitals," they say "can play a unique role in supporting this transformation of the research enterprise."

A comprehensive study using nationwide data on hip and knee replacements in England has found that one in seventy-five patients require a revision of their joint replacement after three years. Although this compares favourably with the rest of the world, the study published in this week's PLoS Medicine reinforces concerns about the new surgical techniques of hip resurfacing and unicondylar knee replacement.

BOSTON, Mass. (September 1, 2008)—Direct-to-consumer advertising may not be giving big pharma such a big bang for their buck after all. Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such strategies have a modest effect at best—and in some cases, no effect at all.

Although most people imagine wolves chasing deer and other hoofed animals, new research suggests that, when they can, wolves actually prefer fishing to hunting. The study, published today in the open access journal BMC Ecology, shows that when salmon is available, wolves will reduce deer hunting activity and instead focus on seafood.

Children burn more than four times as many calories per minute playing an active video game than playing a seated game, and their heart rate is also significantly higher with the active game, according to a report in the September issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

A majority of U.S. hospitals on the East coast distribute formula sample packs to new mothers, contrary to recommendations from most major medical organizations concerned about the potential for distributing these packs to reduce breastfeeding rates, according to a report in the September issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals. However, the practice is changing significantly.

Westchester, Ill.—A study in the Sept. 1 issue of the journal Sleep shows that the subjective interpretation of temperature change is decreased in older adults, particularly those who suffer from insomnia.

Westchester, Ill.— A study in the Sept. 1 issue of the journal Sleep shows that objectively measured heavy snoring is an independent risk factor for early carotid atherosclerosis, which may progress to be associated with stroke.

In a study of 110 adults, the prevalence of carotid atherosclerosis was 20 percent with mild snoring, 32 percent with moderate snoring and 64 percent with heavy snoring. After adjustment for age, gender, smoking history and hypertension, heavy snoring was significantly associated with carotid atherosclerosis.

Bethesda, MD (September 1, 2008) – Non-invasively measuring liver stiffness with transient elastography accurately diagnoses patients with late-stage liver disease, reports a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.

PHOENIX, Ariz. – Sept. 1, 2008 – Researchers at the Translational Genomics Research Institute (TGen) today announced a new approach to treating endometrial cancer patients that not only stops the growth of tumors, but kills the cancer cells.

In a potentially major breakthrough, TGen scientists and collaborators at Washington University School of Medicine in St. Louis discovered that introducing a particular inhibitor drug can turn "off'' receptors responsible for the growth of tumors in a significant number of patients with endometrial cancer.

(PHILADELPHIA)—Researchers at The Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers. The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.

Researchers have attempted for more than a decade to find drugs that shut down telomerase—widely considered the No. 1 target for the development of new cancer treatments—but have been hampered in large part by a lack of knowledge of the enzyme's structure.